Virtus ETF Advisers LLC Bridge Bio Pharma, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 11,357 shares of BBIO stock, worth $269,388. This represents 0.14% of its overall portfolio holdings.

Number of Shares

11,357

Previous 11,357 -0.0%

Holding current value

$269,388

Previous $287,000 0.7%

% of portfolio

0.14%

Previous 0.15%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$23.0 - $31.04 $17,158 - $23,155	746 Added 7.03%	11,357 $287,000
Q1 2024 May 15, 2024	BUY	$27.35 - $40.45 $41,763 - $61,767	1,527 Added 16.81%	10,611 $328,000
Q4 2023 Feb 15, 2024	SELL	$24.02 - $43.89 $214,594 - $392,113	-8,934 Reduced 49.58%	9,084 $366,000
Q3 2023 Nov 07, 2023	SELL	$16.89 - $35.01 $39,303 - $81,468	-2,327 Reduced 11.44%	18,018 $475,000
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $158,190 - $214,373	-11,903 Reduced 36.91%	20,345 $349,000
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $4,065 - $10,517	567 Added 1.79%	32,248 $534,000
Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $30,289 - $51,770	-4,494 Reduced 12.42%	31,681 $241,000
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $4,200 - $6,538	529 Added 1.48%	36,175 $360,000
Q2 2022 Aug 12, 2022	BUY	$5.21 - $12.14 $164,578 - $383,490	31,589 Added 778.63%	35,646 $324,000
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $1,812 - $4,238	-247 Reduced 5.74%	4,057 $41,000
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $11,015 - $51,700	968 Added 29.02%	4,304 $72,000
Q3 2021 Nov 15, 2021	SELL	$46.87 - $64.24 $8,108 - $11,113	-173 Reduced 4.93%	3,336 $156,000
Q2 2021 Aug 10, 2021	SELL	$46.47 - $63.93 $64,732 - $89,054	-1,393 Reduced 28.42%	3,509 $214,000
Q1 2021 May 17, 2021	BUY	$55.47 - $72.35 $4,548 - $5,932	82 Added 1.7%	4,902 $302,000
Q4 2020 Feb 12, 2021	SELL	$38.38 - $71.11 $227,708 - $421,895	-5,933 Reduced 55.18%	4,820 $343,000
Q3 2020 Nov 13, 2020	SELL	$27.2 - $42.19 $39,657 - $61,513	-1,458 Reduced 11.94%	10,753 $403,000
Q2 2020 Aug 05, 2020	BUY	$22.22 - $35.69 $52,239 - $83,907	2,351 Added 23.84%	12,211 $398,000
Q1 2020 May 14, 2020	SELL	$16.11 - $36.23 $23,117 - $51,990	-1,435 Reduced 12.7%	9,860 $286,000
Q4 2019 Feb 13, 2020	BUY	$17.96 - $46.63 $202,858 - $526,685	11,295 New	11,295 $396,000

Others Institutions Holding BBIO

# of Institutions

291

Shares Held

171M

Call Options Held

10.4M

Put Options Held

2.37M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.52B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Bridge Bio Pharma, Inc. Transaction History